Observed Signal · Oct 14, 2026 · Partnership · Source: Tech.eu (European Tech & Deals) · Impact: 2/5 · Sentiment: Neutral
VitVio brings AI surgical OS to Poland with UCK Gdańsk
US-European startup VitVio has partnered with the University Clinical Centre in Gdańsk (UCK) to deploy its AI-powered surgical operating system, Vetro, in Poland for the first time. The system uses computer vision and ambient sensors to create a real-time 3D model of operating rooms, automating tasks like logging surgical milestones and identifying delays. The initial pilot will cover orthopaedics and neurosurgery, with installation coordinated by Polish distributor Medim. VitVio emphasizes clinician privacy, processing data on-premises and deleting original footage. The company has raised $10 million in total funding, including an $8 million seed round led by Bek Ventures. The deployment aims to reduce administrative burden and optimize OR capacity, with potential expansion after pilot evaluation.
The article highlights a partnership between a health-tech startup and a hospital, which is relevant to AI in healthcare but not directly to AdTech/MarTech. However, the AI technology and funding aspects have some relevance to the broader tech ecosystem.
Track ElevenLabs Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- VitVio partners with University Clinical Centre in Gdańsk (UCK) to deploy Vetro in Poland.
- Initial deployment covers orthopaedics and neurosurgery operating rooms.
- Polish distributor Medim coordinates the installation.
- VitVio has raised $10 million total, including an $8 million seed round led by Bek Ventures.
- Vetro uses computer vision and ambient sensing to create real-time 3D models of operating rooms.
Connected Companies & Entities
1 Entity mapped“Its angel investors include ElevenLabs co-founder Mati Staniszewski.”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
XRlabs Raises €7.48M for AI Surgical Intelligence
London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).
Open-Source Model Boosts Global Medical Video AI
United Imaging Intelligence (UII) advances medical video AI through open-source resources, including the uAI NEXUS MedVLM model, the MedVidBench dataset and leaderboard, and the MedVidU Challenge. The challenge, co-launched with University of Strasbourg and Technical University of Munich, attracted 75 teams from 18 countries, including Harvard, Oxford, and NVIDIA. UII released 6,245 MedVidBench test samples in April 2026 and 6,270 more in summer 2026, part of a larger collection of 531,850 video-instruction pairs. The leaderboard evaluates models on ten metrics. MedVidBench surpassed 30,000 downloads within three months. Four teams advanced to the final stage, with two presenting at the ECCV 2026 MedVidU Workshop. This open ecosystem accelerates research in surgical AI, skill assessment, and clinical applications.
Vivodyne builds robotic labs to improve AI drug discovery
Vivodyne, a biotech startup spun out of the University of Pennsylvania, says the AI drug‑discovery field lacks the causal human biological data needed to train useful models and has built HIVE — modular robotic labs that grow human tissues, autonomously dose and monitor them, and generate longitudinal experimental data. The company claims its tissues achieve high concordance with human trial outcomes (e.g., liver 94%, airway 96%, bone marrow 100% on tested chemotherapies), has raised just under $80 million across two rounds led by Khosla Ventures, and last week opened what it calls the world’s largest “human data center” near San Francisco to scale throughput and feed AI research. Vivodyne positions its dataset as a way to enable causal, reinforcement‑learning style models for more predictive human biology and combination‑therapy design.
Receive all future signals for ElevenLabs & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.